HOME >> MEDICINE >> NEWS
Detection of glucose intolerance after heart attack

A Swedish study in this week's issue of THE LANCET confirms that people admitted to hospital with an acute heart attack are at an increased risk of having undiagnosed diabetes or increased glucose intolerance. Findings of the new study suggest that the fasting glucose of patients or high glucose concentrations immediately after heart attack could be a marker of patients at high risk of subsequent cardiovascular disease.

People with diabetes who have myocardial infarction (heart attack) are more likely to die than those without diabetes. Previous research indicates that people with prediabetic conditions, such as impaired glucose tolerance, have an increased risk of cardiovascular disease, and that a blood glucose concentration below the threshold for diabetes is associated with coronary artery disease. Anna Norhammar from the Karolinska Hospital, Stockholm, Sweden, and colleagues aimed to find out the prevalence of impaired glucose metabolism in patients with myocardial infarction but in whom diabetes had not been diagnosed.

181 patients admitted to two Swedish coronary care units with acute myocardial infarction and no diagnosis of diabetes were studied. The investigators recorded glucose concentrations during the hospital stay, and did standardised oral glucose tolerance tests with 75 g of glucose at discharge (four to five days after admission) and again 3 months later.

35% and 40% of patients had impaired glucose tolerance at hospital discharge and after three months, respectively. 31% and 25%, respectively, had previously undiagnosed diabetes. Concentrations of glucose in red blood cells at hospital admission and fasting blood glucose concentrations at discharge were independent predictors of abnormal glucose tolerance.

In an accompanying Commentary, Stephen Haffner from the University of Texas, USA, states: "in view of the high risk of future coronary heart disease in patients with diabetes, it is reasonable to suggest an ora
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-207-424-4949
Lancet
20-Jun-2002


Page: 1 2

Related medicine news :

1. Detection at a distance for more sensitive MRI
2. Detection of antibodies could identify MS pats who do not respond well to interferon beta
3. Detection of glycoprotein could indentify ovarian and uterine cancers with poor prognosis
4. Detection of bioterrorism viruses brought closer to local sites
5. Detection of glucose intolerance after heart attack could identify risk of cardiovascular disease
6. Millions Of Americans With Glaucoma Could Save Sight With Early Detection, Treatment
7. Microwaves May Provide Early Detection Of Breast Cancer
8. Learning From Experience: New Pattern Recognition & Detection Helps Radiologists Analyze Digital Mammograms
9. Elevated glucose levels and diabetes are associated with increased risk for cancer
10. Fatty acid pathway, glucose combine to produce triacetic acid lactone
11. Optical glucose sensor holds promise for diabetics and intensive care patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... ... April 18, 2019 , ... Arnet Pharmaceutical Corporation launched its ... restful sleep to support a healthy mind and body. The single and synergistic ... vitality. , The portfolio includes a total of ten products designed to cover ...
(Date:4/18/2019)... ... April 18, 2019 , ... The Coro Medical official ... Sardis Volunteer Fire Department. , As a small, volunteer-only department in rural Mississippi, ... the community and now, is the only department with life-saving equipment of this caliber ...
(Date:4/17/2019)... ... April 17, 2019 , ... Historically, patients ... reluctance appears to be changing. Whether because of demographic or generational changes, patients ... healthcare providers advice. , In the past, efforts to publish performance data about ...
(Date:4/17/2019)... ... April 17, 2019 , ... Purple Biosciences today ... California-made supplement was designed to lessen the negative effects of alcohol, so ... via GotPurpleTree.com and Amazon.com . , According to the Centers ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... commercialization, has just released the second installment of their two-part white paper series ... The new white paper reviews some of the high-level changes to ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... , ... April 17, 2019 , ... ... providers and patients, announced today it has completed the acquisition of Omni Holdings. ... Omni Holdings is the leading medical lien funding company operating in the Southeastern ...
(Date:4/17/2019)... , ... April 17, 2019 ... ... company focused on novel therapies for diseases involving mitochondrial dysfunction, announced yesterday ... from the Phase 2/3 TAZPOWER and open-label extension (OLE) clinical trial evaluating ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... Pennsylvania, Allegheny Health Network (AHN) and Gateway Health have launched a new program ... of life. , AHN’s Enhanced Pain Management Program brings together a range ...
Breaking Medicine Technology:
Cached News: